Detection of anti-erythropoietin receptor autoantibodies in patients with anemia of chronic disease
| Project/Area Number |
21790803
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Kidney internal medicine
|
|---|
| Research Institution | Kanazawa University |
|---|
Principal Investigator |
HARA Akinori Kanazawa University, 附属病院, 特任助教 (70507045)
|
|---|
| Project Period (FY) |
2009 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Fiscal Year 2010: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2009: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
|---|
| Keywords | 蛋白質 / トランスレーショナルリサーチ / 内科 / 免疫学 / 臨床 |
|---|
| Research Abstract |
We examined the prevalence, clinical associations and pathogenic role of novel autoantibodies to the erythropoietin receptor (EPOR) in patients with anemia of chronic disease (ACD). As a result, serum anti-EPOR antibodies were detected in some patients, but in none of the healthy controls. Sera from patients with anti-EPOR antibodies inhibited EPO-dependent cell proliferation. Among SLE patients studied, anti-EPOR antibodies were associated with reticulocytopenia and a decrease in bone marrow erythroblasts. In conclusion, impaired erythropoiesis may be mediated by anti-EPOR antibodies, which functionally neutralize EPO activity.
|
Report
(3 results)
Research Products
(7 results)
